InvestorsHub Logo
Followers 30
Posts 5081
Boards Moderated 0
Alias Born 01/07/2020

Re: sstyles post# 270739

Friday, 05/01/2020 3:00:36 PM

Friday, May 01, 2020 3:00:36 PM

Post# of 427341
ssstyles@ I also myself only understood this fully yesterday (after Q1 conference).

Settlement with Hikma and Reddy is not an option (wouldn't mean anything) - because of the '6 Patens that judge DU overruled' - the field is' as of right now' - open to any generics in the world 'to copy' and sell 'Vascepa Copy' (generich) in the US.

Only chance to Reverse That is to win the Appeal - why reality is that Amarin has no choice - but to 'go all in' (which is what they do) - In Winning the Appeal.

Jasbg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News